The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Perhaps the MMs have been keeping this stifled to fill that big order.
Would be nice to see us getting over 1p over the next week.
Good luck holders
Oh look, someone agrees and just bought 4 million at 0.816p.
AT tweeted a few weeks ago regarding a ‘material’ announcement that would be forthcoming and got his wrist slapped by the Nomad and put out a ‘Trading statement’ the following morning to ‘update’ the market.
Nothing much has been made of this but again in todays announcement it’s referred to again, ‘material licence fee opportunities’ …..’ and I’m excited to share further information on this in due course’
‘Material’ news is significant in terms of its content as it may affect the price of a stock, either up, or down.
So, excited suggests this ‘material’ news may significantly affect the price of the stock in a positive way.
I too am looking forward to reading about it in due course.
I think the steady stream of RNSs and comments re pipeline etc seems to indicate that the Co seriously wants to put to rest this whole matter of "insufficient cash"; I reckon that by June end, there will a trading update showing exactly how much cash was burned, cash balance etc that should/might assuage these concerns; IMO
Well put David,
The RNS's yesterday and today are showing that the company is working hard on sales and the pipeline has started converting strongly.
I do believe that they will not require another funding now, as they will start getting cash flows from these agreements.
They also still have a lot in the pipeline, and now some relatively small agreements have been made with some big firms it really does bode well for continued business with them.
A contract for £60k today, may turn into repeat business worth a significant amount more over the next year or two.
I believe we will see more of these RNS over the next few weeks, and hopefully that will see a steady growth in the SP.
There's a long way to recover to the value last year, many traders will stunt the movement as they sell for 10% each mini spike (like yesterday morning), but overall I'd be surprised if we were under 1p this time next month, and with consistent updates I can see this going steadily back up, not sure how high though.
Remember even at 5p the Market cap would only be £23m ish and there's a lot of companies out there with bigger all at higher Mcaps.
Good luck holders.
It is the quality and size of the biopharma companies plus Unilever that stands out. These companies are wanting to work with a minnow because Aptamer have something that has value and potential. They will do due diligence and be satisfied.
It is hard to estimate the cash and funding position and whilst a fund raise cannot be ruled out, each new deal lessens the risk and the size of any raise. Posters like Porky may not be wrong but the company continue to develop a pipeline with impressive customers any of which could successfully lead to bigger orders and revenue.
It is the range of possible applications that mean Aptamer have a pivotal role and great potential for others developing important offerings. I certainly feel more confident than three months ago.
Reading the RNS they are expecting further contracts to be announced.
I think this will start to move
When CTO confirms that there won’t be any placing in these levels, I think we will have to trust him on that ! They wouldn’t want to break investor’s trust at these crucial times !
I think Porky could be right despite today's RNS. The sort of money we see coming in from these contracts is not going to stop the need for a raise an it may be prudent for the company to go to market to alleviate any funding concerns.
@iceman - I became a LTH recently seeing the huge potential of this company. BOD have done a great job here. Well settled for a huge rerate. Remember 52 week’s high was 30.50.
GLA
It’s definitely rerate time in my opinion. No risk of placing according to the CTO and revenue flowing from contracts with top companies!
GLA
Excellent work!
Been buying these last few weeks!
This is who the BOD should be updating shareholders. You can tell these people are working hard. Results will come!
GREAT WORK BOD!
YOU HAVE OWN ANOTHER LT HOLDER HERE!
LFG!!!
Contracts confirmed but sales pipeline increasing.
So it looks like they are adding more than converting which is very good.
More contracts to be confirmed
A good update on the progress of our sales pipeline, demonstrating the momentum that is building.
For me, the standout comment is this:
‘An important part of our strategy includes horizon scanning for material licence fee opportunities, and I am excited to share further information on this in due course.’
Material licence opportunities.
That’s what we want here, and there are numerous opportunities.
I haven’t Researched this company too much, but at this price it seemed like a reasonable punt. It’s following similar lines to Avacta.
Maybe wait a couple of hours next tine......
"Company anticipates further contracts, currently in final negotiation stages, will close before the financial year's end"
"Upon success in this project, there is potential for further downstream development contracts for Aptamer. "
"contracts in the pharmaceutical industry often take significant time to negotiate, frequently include confidentiality restrictions, and sometimes do not meet the materiality threshold for individual announcements."
"We continue to make good progress with our developed Optimer assets, with ongoing discussions around our drug delivery vehicles for the liver. Additionally, our work with Unilever developing Optimers in cosmetics applications continues to advance, alongside our partnership with Neuro-Bio to deliver Optimer binders for use in a rapid diagnostic test for Alzheimer's disease."
Porky, we'd call u the "God of Aptamer", u always seem to post prior to a fresh RNS!
Look this is another one where the Directors previously drew the best part of a million quid a year out of it for lavish lifestyles. They only started cutting cost when they had no option, the last raise was subject to that. Old habits die hard, we await to see the full effect of the cost cuts.
Meanwhile, the proof is in the delivery, the H1 confirmed figures were appalling, lets call a spade a spade. Talk of BIG orders worth millions yet they confirmed further declining revenues and Delivered revenue less than my local cafe. No idea why a projected massive order value only results in a paltry actual invoice raised and paid but that was the reality.
Now benefit of the doubt and all that, they may have more jam tomorrow, sorry i mean pipeline, do forgive me but, will that convert to bottom line cash taken in invoices actually raised and paid into the business in the H2?
My call is despite a willingness not to want to raise again so soon, I don't see as they have an option. Unless something material fully paid up lands sharpish, a further raise to meet the current plan objectives looks inevitable to me now but WTFDIK just my opinion. A top up £3m raise at 0.50 or 0.40 would that be enough? extend the runway by 10 months to allow cash to actually land? Not sure
Be interesting how this unfolds short term anyhow, this play is not for widows or orphans that's for sure.
Probably hype but it looks a cheap buy in now imo and they are making progress and I'm very curious to see what happens with the Unilever collaboration.
Koz of projections of high revenues and licensing agreements; delays led to the SP crashing (from a mkt cap of 80mln to 3mln today); licensing deals will eventually come through so the SP will be rerated - just a matter of when.
Just seen this was around a £1 just 2 Years ago. How could it be valued so high then ?
And lastly, a quick "reminder" that the Top 5 Pharma Co is still validating, since January, meaning an RNS could be issued at any moment;
"Developed binders for IHC are now undergoing external validation by a top 5 pharma company, with initial results reported as promising and leading to a commercial request for more material. "
BTW, I did correctly say that (a couple of weeks ago) APTA will be issuing at least 2 RNSs monthly.
GLA